Autres langues Chimerix, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,9529 ^USD	+0,28%		+6,95%	-1,00%

01/05	Transcript : Chimerix, Inc., Q1 2024 Earnings Call, May 01, 2024
01/05	Chimerix, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Chimerix : Corporate Presentation	03/05
Chimerix: Q1 Earnings Snapshot	01/05
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update	01/05
Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024	24/04
Chimerix Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	17/04
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	16/04
Chimerix Appoints Marc D. Kozin to Board of Directors	21/03
Chimerix Appoints Marc D. Kozin to Board of Directors	21/03
Chimerix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Chimerix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Chimerix: Q4 Earnings Snapshot	29/02
Earnings Flash (CMRX) CHIMERIX Reports Q4 Revenue $4,000, vs. Street Est of $70,000	29/02
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update	29/02
Chimerix to Present at TD Cowen 44th Annual Health Care Conference	27/02
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024	22/02
Chimerix Announces Board Changes	29/12
Chimerix Appoints Lisa Decker to Board of Directors	29/12
Chimerix Names Michelle LaSpaluto Finance Chief	04/12
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer	04/12

Aucun résultat pour cette recherche